Plain-English translation of NCT06700538 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new medication called designed to help adults with obesity lose weight. The study will evaluate whether the medication is safe and how well it works, both when used alone and when combined with another diabetes and weight loss medication called . Researchers will monitor participants closely to understand how the medication affects the body and whether it causes any side effects.
Obesity is a serious health condition that is difficult to treat with diet and exercise alone, and many people need additional help to lose weight safely and keep it off. This medication aims to offer a new treatment option for people struggling with obesity, potentially providing better results when used either by itself or alongside existing weight loss medications.
Participants will receive injections of either the new medication or a placebo at scheduled visits over several months. Some participants may also receive weekly doses of starting partway through the study. You will have blood drawn and complete health assessments to monitor how the medication is working and check for any side effects. The entire study may last anywhere from a few months to about a year, depending on which part of the trial you join.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
Australia
Canada